Bon Announces Breakthrough Order for $16 Million Gut-Health Products
Rhea-AI Summary
Bon Natural Life (Nasdaq: BON) has secured a significant $16 million non-exclusive distribution agreement with Beijing Huahai Keyuan Technology for its natural prebiotic product series in China. The 24-month agreement focuses on marketing and distributing BON's advanced gut health products featuring a "Prebiotic + Postbiotic" complex with super prebiotic stachyose as the flagship ingredient.
The partnership leverages Huahai Keyuan's strong market presence and commercialization expertise in China's wellness sector. BON's innovative formulation aims to provide rapid and sustained support for gut microbiota, potentially redefining the gut health market while driving growth and shareholder value.
Positive
- Secured $16 million distribution agreement for gut health products
- 24-month partnership with established Chinese wellness company
- Entry into China's rapidly growing gut health market
- Innovative product featuring advanced Prebiotic + Postbiotic complex
Negative
- Non-exclusive distribution agreement limits market protection
- Revenue generation dependent on partner's sales performance
News Market Reaction
On the day this news was published, BON gained 18.70%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BON believes their latest natural prebiotic product series marks a significant step forward in gut health, featuring a cutting-edge "Prebiotic + Postbiotic" complex centered on its flagship active ingredient: super prebiotic stachyose. This advanced formulation intends to deliver rapid, robust, and sustained support for gut microbiota, promoting a multi-fold increase in beneficial probiotic populations within a short period while maintaining excellent stability.
With its efficacy and market potential, this solution is poised to help redefine the future of gut health.
Yongwei Hu , Chairman and CEO of BON, stated "As a global leader in 'prebiotic + postbiotic' health solutions, we are thrilled to launch a premium gut health product with robust and sustained bioactive properties, and to establish a distribution partnership with Huahai Keyuan—an organization well-regarded for its strong market presence and commercialization expertise." Mr. Hu added "Huahai Keyuan brings deep experience in introducing innovative health products to the Chinese market, with a proven track record in market expansion and brand development."
Mr. Hu further stated, "At BON, we believe this strategic collaboration will accelerate our entry into
Additionally, Mr. Hu also stated: "This partnership with Huahai Keyuan marks a transformative step in scaling our integrated gut health solutions. We anticipate strong commercial outcomes that will drive both top-line growth and long-term shareholder value."
About Bon Natural Life Limited ("BON")
BON is a
For more information, please contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes,""expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/bon-announces-breakthrough-order-for-16-million-gut-health-products-302496652.html
SOURCE Bon Natural Life Limited
FAQ
What is the value of BON's new distribution agreement with Huahai Keyuan?
What products will Huahai Keyuan distribute for BON?
How long is BON's distribution agreement with Huahai Keyuan?
What is unique about BON's new gut health product?
Who is Huahai Keyuan and why did BON choose them as a distributor?
